Every year, more than 178 million people worldwide suffer from bone fracture injuries. The current methods of pain management, typically relying on nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin, have their limitations.

A single dose of this state-of-the-art medication has the potential to offer significant relief to patients, according to lab trials involving mice.

Two new studies have found that steroid injections for knee pain related to osteoarthritis can actually make things worse for patients.

Researchers say that monoclonal antibodies have the potential as a monthly non-addictive pain medication that can replace opioids for people with chronic pain.

Whether it's a headache, a bruised muscle, or recovery from an injury, it's almost instinctual for many people to quickly turn to common painkillers for immediate relief.

A new medical procedure could help to improve the quality of life for millions of people who have to undergo knee replacement surgery.